Cargando…
Effectiveness of CoronaVac in children 3–5 years of age during the SARS-CoV-2 Omicron outbreak in Chile
The outbreak of the B.1.1.529 lineage of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (Omicron) has caused an unprecedented number of Coronavirus Disease 2019 (COVID-19) cases, including pediatric hospital admissions. Policymakers urgently need evidence of vaccine effectiveness in ch...
Autores principales: | Jara, Alejandro, Undurraga, Eduardo A., Zubizarreta, José R., González, Cecilia, Acevedo, Johanna, Pizarro, Alejandra, Vergara, Verónica, Soto-Marchant, Mario, Gilabert, Rosario, Flores, Juan Carlos, Suárez, Pamela, Leighton, Paulina, Eguiguren, Pablo, Ríos, Juan Carlos, Fernandez, Jorge, García-Escorza, Heriberto, Araos, Rafael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9307483/ https://www.ncbi.nlm.nih.gov/pubmed/35605637 http://dx.doi.org/10.1038/s41591-022-01874-4 |
Ejemplares similares
-
Neutralizing antibodies induced by homologous and heterologous boosters in CoronaVac vaccines in Chile
por: Acevedo, Johanna, et al.
Publicado: (2023) -
Effectiveness of an Inactivated SARS-CoV-2 Vaccine in Chile
por: Jara, Alejandro, et al.
Publicado: (2021) -
Effectiveness of the second COVID-19 booster against Omicron: a large-scale cohort study in Chile
por: Jara, Alejandro, et al.
Publicado: (2023) -
Boosting immunity after CoronaVac
por: Sester, Martina, et al.
Publicado: (2022) -
Immunogenicity of Mix-and-Match CoronaVac/BNT162b2 Regimen versus Homologous CoronaVac/CoronaVac Vaccination: A Single-Blinded, Randomized, Parallel Group Superiority Trial
por: Samoud, Samar, et al.
Publicado: (2023)